Avigilon Corp. Is a Growth Puzzle

Avigilon Corp. (TSX:AVO) is one of a select few Canadian growth gems in the technology space that has puzzled investors over the past few years. Here’s why.

Avigilon Corp. (TSX:AVO) is one of a select few Canadian growth gems in the technology space that has puzzled investors over the past few years. The company has been trading on the TSX for just over five years, and in that span, the business’ stock price has gone through a number of boom and bust cycles, based on how the company managed to meet, exceed, or underperform growth expectations set internally and by the market.

Growth company

As a growth company, Avigilon has done a relatively good job of hitting its own preset targets over the medium term. At the time of the company’s initial public offering (IPO), management set a target revenue run rate of $500 million as the goal to be achieved in five years; five years later, the company has accomplished mission #1 and is now moving on to bigger and better things.

The issue that management has had in meeting its revenue run rate target is that the industry has evolved over the past five years, resulting in increased competition and squeezed margins, factors which have led to an overall stock price decline from the valuation reached in 2014 despite growth numbers largely meeting expectations over the long-term.

From 2014 to 2016, the company’s gross margin has decreased from 56.6% to 52% for a number of reasons linked to the company’s revenue growth model. While going after market share in the growing surveillance systems market seems to be a prudent long-term strategy, eroding margins and increased competition for market share has led to less-enticing results over the past couple years on the whole.

Growth slowing

As Avigilon and its competition are finding out, achieving high levels of growth year over year becomes more and more difficult the larger the business grows. Capturing low-hanging fruit out of the gate enabled Avigilon to grow at hyper-speed, and the company is starting to see these growth rates slow down in recent years, although the trend is still positive.

In 2016, the company grew EBITDA by 6% and in 2015, the growth rate was 4.9%, a far cry from EBITDA growth rates in the 300%-600% range from 2009 through 2013. Growth in EBITDA has been slowed partly due to the aforementioned deterioration in margins of late; over the past eight quarters, gross margin has declined from 59% in Q1 2015 to 51% in Q4 2016, finding what appears to be a “new normal” gross margin closer to 50% than 60%.

Bottom line

Avigilon is an atypical stock, one which provides long-term investors continued headaches due to the changing characteristics of the industry and underlying business, making forecasting assumptions opaque and financial modeling efforts difficult. In my opinion, Avigilon is at a stage where margin preservation means more to me than capturing market share, and as a result, I remain on the sidelines.

Stay Foolish, my friends.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any stocks mentioned.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »